Clinical Trial Update: Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating pirfenidone capsules for radiation-induced lung injury with or without immune-related pneumonia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune-related Pneumonia
• Radiation-induced Lung Injury

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Radiation-induced Lung Injury, Immune-related Pneumonia | Phase 2, Phase 3 | Status: RECRUITING